Patents by Inventor Krishnaswamy Yeleswaram

Krishnaswamy Yeleswaram has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TOPICAL FORMULATION FOR A JAK INHIBITOR
    Publication number: 20150250790
    Abstract: This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.
    Type: Application
    Filed: May 18, 2015
    Publication date: September 10, 2015
    Applicant: INCYTE CORPORATION
    Inventors: Bhavnish Parikh, Bhavesh Shah, Krishnaswamy Yeleswaram
  • SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR
    Publication number: 20150065484
    Abstract: This invention relates to sustained release dosage forms comprising {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl}-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile, or a pharmaceutically acceptable salt thereof, and doses and methods related thereto.
    Type: Application
    Filed: August 6, 2014
    Publication date: March 5, 2015
    Applicant: Incyte Corporation
    Inventors: Krishnaswamy Yeleswaram, Bhavnish Parikh, Dilip P. Modi, Trupti Sheth
  • SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB
    Publication number: 20140135350
    Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
    Type: Application
    Filed: November 14, 2013
    Publication date: May 15, 2014
    Applicant: Incyte Corporation
    Inventors: Yong Ni, Bhavnish Parikh, Krishnaswamy Yeleswaram, Susan Erickson-Viitanen, William V. Williams
  • TOPICAL FORMULATION FOR A JAK INHIBITOR
    Publication number: 20110288107
    Abstract: This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.
    Type: Application
    Filed: May 20, 2011
    Publication date: November 24, 2011
    Inventors: BHAVNISH PARIKH, BHAVESH SHAH, KRISHNASWAMY YELESWARAM
  • Dosing methods for beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy
    Publication number: 20050244490
    Abstract: The disclosed invention is a composition for and a method of treating a HIV infection in a host, such as a human, using a single, once a day, oral dose of ?-D-D4FC in an enteric-coated tablet. The enterically coated ?-D-D4FC increases the amount of the drug that remains in active form for use in inhibiting the HIV virus in vivo.
    Type: Application
    Filed: December 9, 2004
    Publication date: November 3, 2005
    Inventors: Michael Otto, Abel Rosa, Krishnaswamy Yeleswaram